Pulmonary Hypertension Clinical Trial
Official title:
Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post Bronchoscopic Volume Reduction by Histoacryl or Silver Nitrate (Single Center Experince )
This study is designed as a prospective study, with the primary endpoint being changes in
pulmonary hemodynamic parameters after ELVR in patients with severe emphysema.
Secondary endpoints will be changes in lung function parameters, exercise capacity, and QoL.
Chronic obstructive pulmonary disease (COPD) continues to be a leading cause of morbidity
and is currently the third most common cause of mortality worldwide (1).
In most patients with severe COPD, chronic airflow limitation, lung emphysema with
parenchymal destruction and the development of air bullae also occur (2-3) Pulmonary
hypertension (PH) is a common consequence of COPD, although the actual overall prevalence of
PH in COPD remains unclear (4). Among COPD patients who were to undergo
lung-volume-reduction surgery or lung transplantation, mild PH was observed in 50.2%,
moderate PH in 9.8%, and severe PH in 3.7%(5). While in most COPD patients who develop PH,
pulmonary arterial pressure is only mildly or moderately elevated, (6) PH has an independent
prognostic impact on survival. (6,7) The therapeutic options for COPD patients with severe
emphysema are limited. Lung volume reduction surgery (LVRS) has been performed as treatment
in selected cases, but the referral of patients has been severely influenced by the marked
perioperative morbidity and mortality [8]. Less invasive techniques have been developed with
the aim of improving patients' pulmonary function, symptoms, and quality of life (QoL) [9].
Among them, the one most commonly used is the endoscopic placement of one way endobronchial
valves (EBV) [10-12]. So far patients with severe emphysema and established PH have been
excluded from LVRS as well as from endoscopic lung volume reduction (ELVR) therapy.
Whether bronchoscopic lung volume reduction in COPD patients with silver nitrate or
histoacryl influences the severity of PH in patients with severe emphysema and PH has yet to
be elucidated.
This study is designed as a prospective pilot study, with the primary endpoint being changes
in pulmonary hemodynamic parameters after ELVR in patients with severe emphysema.
Secondary endpoints will be changes in lung function parameters, exercise capacity, and QoL.
Materials and Methods This is Prospective descriptive study on 20 COPD Patients with
predominant emphysema especially with heterogeneous and upper lobe predominance emphysema
admitted in chest department at Kasr al Ainy Hospital. All patients will be on optimal
medical treatment for COPD according to Global Initiative for Chronic Obstructive Lung
Disease guidelines [13] All patients will be subjected to the following at base line.
1. full history taking.
2. full clinical examination.
3. plain chest x ray.
4. an electrocardiogram, High resolution computed tomography of the chest.
5. Pulmonary function tests and ABG.
6. 6-minute walk test.
7. 2-D echocardiography at rest
8. Right heart catheterization (RHC)
9. Fiberoptic bronchoscopy with application of silver nitrate or histoacryl. The patients
will be followed up every month by
1. Dyspnea score (using mMRC score) 2. 6-minute walk test. 3. ECG At 3rd Month 2-D
echocardiography at rest will be done At 6th Month 2-D echocardiography at rest And RHC will
be done .
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01950585 -
Hydroxyurea in Pulmonary Arterial Hypertension
|
Early Phase 1 | |
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
Recruiting |
NCT04554160 -
Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring
|
||
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT01894035 -
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
|
||
Not yet recruiting |
NCT04083729 -
Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy
|
N/A | |
Terminated |
NCT02246348 -
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
|
N/A | |
Completed |
NCT02821156 -
Study on the Use of Inhaled NO (iNO)
|
N/A | |
Completed |
NCT02216279 -
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
|
Phase 2 | |
Terminated |
NCT02243111 -
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
|
N/A | |
Recruiting |
NCT01913847 -
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT06240871 -
Contrast Enhanced PA Pressure Measurements
|
||
Completed |
NCT02377934 -
Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
|
||
Recruiting |
NCT01091012 -
Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT01463514 -
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
|
N/A | |
Completed |
NCT01484899 -
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
|
N/A | |
Completed |
NCT00739375 -
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.
|
Phase 1 | |
Completed |
NCT02275793 -
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
|